Moderator Keynote Speakers
Hsueh-Chia Chang
Bayer Professor of Chemical and Biomolecular Engineering, University of Notre Dame, Interim Chief Technology Officer, Aopia Biosciences | 
Chwee Teck Lim
NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore | 
Dino Di Carlo
Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Vice Chair of Bioengineering, University of California-Los Angeles | 
Michael Heller
Professor, Dept Bioengineering, University of California-San Diego | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas | 
Arben Merkoçi
ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Català de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST) |
|
John Brennan
Professor and Director, Biointerfaces Institute, McMaster University | 
Bernhard Weigl
Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund | 
Martyn Boutelle
Professor of Biomedical Sensors Engineering, Imperial College London |
OverviewWelcome to the SELECTBIO Point-of-Care Diagnostics and Global Health 2018.This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health
fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in
these fields and offer networking and engagement opportunities with
delegates from around the world. This conference will provide an
overview of the point-of-care (POC) testing landscape, from novel
technologies to regulatory approval. Experts in these fields will share
their views on point-of-care in the clinical setting. The aim of this
meeting is to bring together life science researchers that work at the
interface between biology and chemistry and technology development to
discuss problems, highlight solutions and facilitating collaborations.
Also, we frame the role of POC testing in the expanding Global Health
field and highlight opportunities existing in many parts of the world. This
conference covers POC Detection, POC Diagnostics and POC-based
Treatment Options as part of the Comprehensive Coverage of this
Expanding Field. The POC testing field is expanding focused not only on
infectious disease diagnostics (which represents approximately 80% of
the marketplace) but also with cancer and cardiovascular disease focus.
We address each of these segments in this conference. Registered conference delegates have full access to the co-located parallel conferences: - Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2018
- Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 2018
- Point-of-Care Diagnostics and Global Health 2018
- Single Cell Analysis Summit 2018
Information and Local Registration Facilities for this Conference are also available in:
 Japanese
|
 Korean
|
 Chinese (Simplified)
|
 Chinese (Traditional)
Agenda Topics- Emerging Technologies and Emerging Companies Showcase
- Global Health and Emerging Viral Diseases such as Ebola and Zika
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Innovations in Technology Development
- POC Diagnostics for Global Health: A Worldwide Perspective
- Low-Cost POC Devices for Deployment Worldwide
- POC Diagnostics in Resource-Limited Settings
- POC Diagnostics in Infectious Disease Testing
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Confirmed Speakers to dateAmy Adelberger, Founder and CEO, Global Impact Advisors
Charles Daitch, CEO, Akonni Biosystems Inc.
James Downs, Global Business Development Manager, SCHOTT Nexterion
Paul Fleming, Program Director & Director of Site Operations, Ximedica
Jim Gallarda, Senior Program Officer, Bill & Melinda Gates Foundation
Luke Helm, Director of Business Development, Symbient Product Development
Hsuan-Yu Leu, Researcher, University of Utah
Robert Meagher, Principal Member of the Technical Staff, Sandia National Laboratories
Fred Mitchell, Engineering Development Manager, Wi, Inc.
Claudio Parolo, Research Fellow, University of California-Santa Barbara
Alexandra Perebikovsky, Researcher, University of California-Irvine
Chaminda Salgado, Cell & Gene Therapy Medicinal Process Delivery Leader, GlaxoSmithKline
Paul Yager, Professor, Department of Bioengineering, University of Washington and CSO, UbiDX, Inc.
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2018-10-01 00:00:002018-10-03 00:00:00Europe/LondonPoint-of-Care Diagnostics and Global Health 2018Point-of-Care Diagnostics and Global Health 2018 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com
